Order Article Reprints

Rehues P, Girona J, Guardiola M, Plana N, Scicali R, Piro S, Muñiz-Grijalvo O, Díaz-Díaz JL, Recasens L, Pinyol M, et al. PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk. International Journal of Molecular Sciences. 2023; 24(3):2319. https://doi.org/10.3390/ijms24032319

Rehues, Pere, Josefa Girona, Montse Guardiola, Núria Plana, Roberto Scicali, Salvatore Piro, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Lluís Recasens, Marta Pinyol, and et al. 2023. "PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk" International Journal of Molecular Sciences 24, no. 3: 2319. https://doi.org/10.3390/ijms24032319

Rehues, P., Girona, J., Guardiola, M., Plana, N., Scicali, R., Piro, S., Muñiz-Grijalvo, O., Díaz-Díaz, J. L., Recasens, L., Pinyol, M., Rosales, R., Esteban, Y., Amigó, N., Masana, L., Ibarretxe, D., & Ribalta, J. (2023). PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk. International Journal of Molecular Sciences, 24(3), 2319. https://doi.org/10.3390/ijms24032319